NO942241D0 - Fremgangsmåte for behandling av osteoporose ved behandling av bisfosfonater og parathyreoideahormon - Google Patents
Fremgangsmåte for behandling av osteoporose ved behandling av bisfosfonater og parathyreoideahormonInfo
- Publication number
- NO942241D0 NO942241D0 NO942241A NO942241A NO942241D0 NO 942241 D0 NO942241 D0 NO 942241D0 NO 942241 A NO942241 A NO 942241A NO 942241 A NO942241 A NO 942241A NO 942241 D0 NO942241 D0 NO 942241D0
- Authority
- NO
- Norway
- Prior art keywords
- bisphosphonates
- treatment
- parathyroid hormone
- treating osteoporosis
- osteoporosis
- Prior art date
Links
- 229940122361 Bisphosphonate Drugs 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 102000003982 Parathyroid hormone Human genes 0.000 title 1
- 108090000445 Parathyroid hormone Proteins 0.000 title 1
- 150000004663 bisphosphonates Chemical class 0.000 title 1
- 239000000199 parathyroid hormone Substances 0.000 title 1
- 229960001319 parathyroid hormone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80962091A | 1991-12-17 | 1991-12-17 | |
PCT/US1992/010869 WO1993011786A1 (en) | 1991-12-17 | 1992-12-15 | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942241D0 true NO942241D0 (no) | 1994-06-15 |
NO942241L NO942241L (no) | 1994-08-09 |
Family
ID=25201804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942241A NO942241D0 (no) | 1991-12-17 | 1994-06-15 | Fremgangsmåte for behandling av osteoporose ved behandling av bisfosfonater og parathyreoideahormon |
Country Status (18)
Country | Link |
---|---|
US (1) | US5616560A (no) |
EP (1) | EP0618805A1 (no) |
JP (1) | JPH07502507A (no) |
AU (2) | AU3322593A (no) |
BR (1) | BR9206941A (no) |
CA (1) | CA2124792C (no) |
CZ (1) | CZ282889B6 (no) |
FI (1) | FI942884A (no) |
HU (1) | HUT68010A (no) |
IL (1) | IL104108A (no) |
MA (1) | MA23079A1 (no) |
MX (1) | MX9207349A (no) |
NO (1) | NO942241D0 (no) |
NZ (1) | NZ246456A (no) |
RU (2) | RU2112515C1 (no) |
SK (1) | SK74594A3 (no) |
WO (1) | WO1993011786A1 (no) |
ZA (1) | ZA929758B (no) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3322593A (en) * | 1991-12-17 | 1993-07-19 | Procter & Gamble Pharmaceuticals, Inc. | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
AU4859493A (en) * | 1992-10-09 | 1994-05-09 | Upjohn Company, The | Pyrimidine bisphosphonate esters and (alkoxymethylphosphinyl)alkyl phosphonic acids as anti-inflammatories |
US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
JPH10505091A (ja) * | 1994-09-09 | 1998-05-19 | ザ、プロクター、エンド、ギャンブル、カンパニー | 骨粗鬆症用のホスホネート及び副甲状腺ホルモン |
WO1996007417A1 (en) * | 1994-09-09 | 1996-03-14 | The Procter & Gamble Company | Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
US5747456A (en) * | 1994-12-19 | 1998-05-05 | Beth Israel Deaconess Medical Center | Continuous low-dose administration of parathyroid hormone or its agonist |
AU4472896A (en) * | 1994-12-19 | 1996-07-10 | Beth Israel Hospital Association, The | Continuous low-dose administration of parathyroid hormone or its agonist |
BR9510123A (pt) * | 1994-12-28 | 1997-12-30 | Gador Sa | Composição anabólica da massa óssea |
US5616571A (en) * | 1995-06-06 | 1997-04-01 | Merck & Co., Inc. | Bisphosphonates prevent bone loss associated with immunosuppressive therapy |
US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
SE9702401D0 (sv) | 1997-06-19 | 1997-06-19 | Astra Ab | Pharmaceutical use |
EP0891779A1 (de) * | 1997-06-19 | 1999-01-20 | Roche Diagnostics GmbH | Pharmazeutische Kombinationspräparate enthaltend Parathyroidhormon und Calcium- und/oder Phosphatverbindungen |
US6015801A (en) * | 1997-07-22 | 2000-01-18 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US5994329A (en) * | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6432932B1 (en) | 1997-07-22 | 2002-08-13 | Merck & Co., Inc. | Method for inhibiting bone resorption |
US6770623B1 (en) * | 1997-12-09 | 2004-08-03 | Eli Lilly And Company | Stabilized teriparatide solutions |
EP0922467A3 (en) * | 1997-12-12 | 2000-05-24 | Takeda Chemical Industries, Ltd. | Iontophoretic drug delivery |
US6495662B1 (en) * | 1998-10-22 | 2002-12-17 | The General Hospital Corporation | Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
WO2000032771A1 (en) * | 1998-11-30 | 2000-06-08 | The General Hospital Corporation | Pth1r and pth3r receptors, methods and uses thereof |
SE9901572D0 (sv) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
AUPQ232599A0 (en) * | 1999-08-19 | 1999-09-09 | Royal Alexandra Hospital For Children, The | Drug for treating fractures |
AU7734800A (en) * | 1999-09-29 | 2001-04-30 | General Hospital Corporation, The | Polypeptide derivatives of parathyroid hormone (pth) |
ES2394211T3 (es) | 2000-06-20 | 2013-01-23 | Novartis Ag | Procedimiento de administración de bifosfonatos |
CA2372450A1 (en) * | 2001-05-10 | 2001-09-19 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
KR100491737B1 (ko) * | 2001-07-20 | 2005-05-27 | 주식회사 한국아이템개발 | 공기 정화 기능의 모기 퇴치기 |
JP4837888B2 (ja) | 2001-07-23 | 2011-12-14 | ザ ジェネラル ホスピタル コーポレイション | コンホメーションが拘束された副甲状腺ホルモン(pth)類似体 |
DE60233803D1 (de) * | 2001-08-17 | 2009-11-05 | Novartis Ag | 5-cnac zur oralen verabreichung von parathormonfragmenten |
AU2003226148A1 (en) * | 2002-04-05 | 2003-10-27 | Merck & Co., Inc. | Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
DK1880744T3 (en) | 2002-05-10 | 2015-02-09 | Hoffmann La Roche | Bisphosphonic acids for the treatment and prevention of osteoporosis |
US20040097468A1 (en) * | 2002-11-20 | 2004-05-20 | Wimalawansa Sunil J. | Method of treating osteoporosis and other bone disorders with upfront loading of bisphosphonates, and kits for such treatment |
AU2003220380A1 (en) * | 2003-03-19 | 2004-11-19 | Bristol-Myers Squibb Company | CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH Alpha-HELIX STABILIZERS |
PL1635875T3 (pl) * | 2003-06-26 | 2009-03-31 | Psivida Inc | System dostarczania leków poprzez żelowanie w warunkach in-situ |
EP1653985A4 (en) | 2003-07-17 | 2009-08-05 | Gen Hospital Corp | CONSTRAINTS CONTAINING CONTAINING HORMONE PARATHYROID (PTH) ANALOGUES |
JP2007501241A (ja) * | 2003-08-06 | 2007-01-25 | ローディア インコーポレイティド | 骨成長を促進する方法 |
WO2005018640A1 (en) * | 2003-08-20 | 2005-03-03 | The Procter & Gamble Company | Kit for treatment of upper gastrointestinal tract conditions |
US20050261250A1 (en) * | 2004-05-19 | 2005-11-24 | Merck & Co., Inc., | Compositions and methods for inhibiting bone resorption |
US7994129B2 (en) * | 2005-11-10 | 2011-08-09 | Michigan Technological University | Methods of using black bear parathyroid hormone |
JP2009545320A (ja) * | 2006-08-04 | 2009-12-24 | ザ ジェネラル ホスピタル コーポレイション | 副甲状腺ホルモン(pth)のポリペプチド誘導体 |
CA2687903C (en) * | 2007-05-24 | 2016-09-13 | Ablynx N.V. | Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
CA3017668C (en) * | 2007-08-01 | 2021-11-09 | The General Hospital Corporation | Screening methods using g-protein coupled receptors and related compositions |
EP2509996A1 (en) | 2009-12-07 | 2012-10-17 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
US8882740B2 (en) * | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
BR112012028949B1 (pt) | 2010-05-13 | 2020-11-17 | Chugai Seiyaku Kabushiki Kaisha | polipeptídeo análogo do hormônio paratireoideo, seu uso e método de produção, bem como ácido nucleico, vetor de expressão, célula e composição farmacêutica |
WO2016163886A2 (en) | 2015-04-10 | 2016-10-13 | Clues2Cure International B.V. | Administration of taurine or an analog thereof for the treatment of nerve cell damage |
CA3101326C (en) | 2018-10-29 | 2023-08-01 | Asahi Kasei Pharma Corporation | Method for preventing or treating osteoporosis, characterized by administering teriparatide or salt thereof at a frequency of twice a week |
EP3875105A4 (en) * | 2018-10-29 | 2022-06-29 | Asahi Kasei Pharma Corporation | Method for preventing or treating osteoporosis characterized by administering teriparatide or salt thereof twice a week |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4086196A (en) * | 1975-03-28 | 1978-04-25 | Armour Pharmaceutical Company | Parathyroid hormone |
DE3243358A1 (de) * | 1982-11-24 | 1984-05-24 | Rolf Dieter Prof.Dr. 3004 Isernhagen Hesch | Synthetisches humanes (1-38) parathormon-fragment, verfahren zu seiner herstellung und die verwendung zur behandlung der osteoporose |
US4812311A (en) * | 1984-12-21 | 1989-03-14 | The Procter & Gamble Company | Kit for use in the treatment of osteoporosis |
US4812304A (en) * | 1984-12-21 | 1989-03-14 | The Procter & Gamble Company | Treatment of osteoporosis |
US4822609A (en) * | 1984-12-21 | 1989-04-18 | The Procter & Gamble Company | Treatment of osteoporosis |
IL78342A (en) * | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
US4761406A (en) * | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
DE3935738A1 (de) * | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff |
AU3322593A (en) * | 1991-12-17 | 1993-07-19 | Procter & Gamble Pharmaceuticals, Inc. | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
-
1992
- 1992-12-15 AU AU33225/93A patent/AU3322593A/en not_active Withdrawn
- 1992-12-15 CZ CZ941477A patent/CZ282889B6/cs not_active IP Right Cessation
- 1992-12-15 CA CA002124792A patent/CA2124792C/en not_active Expired - Fee Related
- 1992-12-15 SK SK745-94A patent/SK74594A3/sk unknown
- 1992-12-15 NZ NZ246456A patent/NZ246456A/en unknown
- 1992-12-15 RU RU94031209A patent/RU2112515C1/ru active
- 1992-12-15 EP EP93901282A patent/EP0618805A1/en not_active Withdrawn
- 1992-12-15 WO PCT/US1992/010869 patent/WO1993011786A1/en not_active Application Discontinuation
- 1992-12-15 JP JP5511155A patent/JPH07502507A/ja active Pending
- 1992-12-15 BR BR9206941A patent/BR9206941A/pt not_active Application Discontinuation
- 1992-12-15 HU HU9401798A patent/HUT68010A/hu unknown
- 1992-12-16 RU RU92004521A patent/RU2104699C1/ru active
- 1992-12-16 MA MA23039A patent/MA23079A1/fr unknown
- 1992-12-16 IL IL10410892A patent/IL104108A/en not_active IP Right Cessation
- 1992-12-16 AU AU30226/92A patent/AU663348B2/en not_active Ceased
- 1992-12-17 ZA ZA929758A patent/ZA929758B/xx unknown
- 1992-12-17 MX MX9207349A patent/MX9207349A/es unknown
-
1994
- 1994-06-15 NO NO942241A patent/NO942241D0/no unknown
- 1994-06-16 FI FI942884A patent/FI942884A/fi unknown
-
1996
- 1996-03-20 US US08/619,103 patent/US5616560A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU3322593A (en) | 1993-07-19 |
HU9401798D0 (en) | 1994-09-28 |
RU2112515C1 (ru) | 1998-06-10 |
AU663348B2 (en) | 1995-10-05 |
AU3022692A (en) | 1993-06-24 |
RU94031209A (ru) | 1996-07-27 |
MX9207349A (es) | 1993-12-01 |
CA2124792A1 (en) | 1993-06-24 |
US5616560A (en) | 1997-04-01 |
NO942241L (no) | 1994-08-09 |
EP0618805A1 (en) | 1994-10-12 |
SK74594A3 (en) | 1995-01-12 |
CA2124792C (en) | 2000-07-04 |
CZ282889B6 (cs) | 1997-11-12 |
MA23079A1 (fr) | 1993-07-01 |
FI942884A0 (fi) | 1994-06-16 |
NZ246456A (en) | 1997-03-24 |
FI942884A (fi) | 1994-06-16 |
IL104108A (en) | 1999-09-22 |
ZA929758B (en) | 1993-09-10 |
IL104108A0 (en) | 1993-05-13 |
BR9206941A (pt) | 1995-05-02 |
WO1993011786A1 (en) | 1993-06-24 |
CZ147794A3 (en) | 1994-12-15 |
JPH07502507A (ja) | 1995-03-16 |
HUT68010A (en) | 1995-05-29 |
RU2104699C1 (ru) | 1998-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO942241D0 (no) | Fremgangsmåte for behandling av osteoporose ved behandling av bisfosfonater og parathyreoideahormon | |
GB2259185B (en) | Method and apparatus for surface treatment | |
EP0303339A3 (en) | Method and apparatus for treating sludges | |
GB2263244B (en) | Method of and apparatus for di can surface treatment | |
EP0454122A3 (en) | Method and apparatus for treating medical wastes | |
ZA914556B (en) | Intramedullary nailing method and apparatus | |
EP0443154A3 (en) | Apparatus for and method of surface treatment for microelectronic devices | |
CS66192A3 (en) | Process and apparatus for waste heat treatment | |
EP0481506A3 (en) | Method of treating substrate and apparatus for the same | |
SG48279A1 (en) | Method and apparatus for the surface treatment of parts | |
IL104940A0 (en) | Method and composition for the treatment of osteoporosis | |
EP0252479A3 (en) | Method for surface treatment and treating material therefor | |
NO972426D0 (no) | Metode for anvendelse av triarylethylenderivater ved behandling og forhindring av osteoporose | |
GB2261832B (en) | Method of treating waste and apparatus for use in the method | |
GB9321900D0 (en) | Method and apparatus for the treatment of semiconductor substrates | |
IL102406A0 (en) | Method and apparatus for treating tissue | |
IL100750A0 (en) | Method and apparatus particularly useful for treating osteoporosis | |
GB2310446B (en) | Surface treatment apparatus and method | |
EP0454169A3 (en) | Photomask and method of treating the same | |
GB2286344B (en) | Liquid treatment apparatus and method | |
EP0692965A4 (en) | METHOD AND COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS | |
GB9407507D0 (en) | Method for treating reinforced concrete and/or the reinforcemtnt thereof | |
KR950701012A (ko) | 금속을 처리하기 위한 조성물 및 방법(composition and process for treating metal) | |
GB9014891D0 (en) | Method and apparatus for ground treatment | |
IL105522A0 (en) | Substrate treatment method and apparatus |